Position in LLY
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$78,286,802
+$52,995,887 QoQ
Shares Held
65,270
+137.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
1.85%
of 13F equity value
Holder Rank
#432
of 4,605 holders
Holding Since
Jun 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026E. Ohman J:or Asset Management AB holds $142,928,858 across 9 Drug Manufacturers - General names. LLY ranks #1 (54.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
65,270 | $78,286,802 | |
| 2 | ABBV |
AbbVie Inc.
|
62,362 | $15,692,773 | |
| 3 | JNJ |
Johnson & Johnson
|
59,384 | $15,081,754 | |
| 4 | MRK |
Merck & Co., Inc.
|
87,897 | $11,294,764 | |
| 5 | AMGN |
Amgen Inc
|
19,515 | $7,066,771 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
44,792 | $5,659,021 | |
| 7 | PFE |
Pfizer Inc
|
199,117 | $4,794,737 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
69,612 | $4,011,043 |
All Filings in LLY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,286,802 | 65,270 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $25,290,915 | 27,497 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $29,366,708 | 27,326 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $31,725,540 | 41,580 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $31,206,924 | 40,033 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $76,971,508 | 93,196 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $69,676,088 | 90,254 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $64,669,190 | 72,995 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $59,827,510 | 66,080 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $48,381,332 | 62,190 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $22,967,048 | 39,400 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $12,190,702 | 22,696 | Shares | Sole | 2024-02-06 | |
| 2023-06-30 | $6,610,742 | 14,096 | Shares | Sole | 2024-04-05 | |
| 2023-03-31 | $6,557,948 | 19,096 | Shares | Sole | 2024-04-05 | |
| 2022-12-31 | $5,888,560 | 16,096 | Shares | Sole | 2024-04-05 | |
| 2022-09-30 | $5,204,641 | 16,096 | Shares | Sole | 2024-04-05 | |
| 2021-12-31 | $10,993,556 | 39,800 | Shares | Sole | 2024-04-05 | |
| 2021-06-30 | $4,728,112 | 20,600 | Shares | Sole | 2024-04-05 | |
| No filing history on record for this holder in this stock. | ||||||